NCT03724812 - FlexNav EU CE Mark Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

January 14, 2020

Study Completion Date

February 10, 2021

Conditions

Symptomatic Severe Aortic Stenosis

Interventions

DEVICE

Portico Valve and FlexNav™ Delivery System

Subjects will undergo transcatheter aortic valve replacement (TAVR) with the Portico valve and second-generation FlexNav Delivery system via a transfemoral access approach

Trial Locations (6)

2100

Rigshospitalet, Copenhagen

8091

Universitaets Spital Zuerich, Zurich

9007

Kantonsspital St. Gallen, Sankt Gallen

20097

Policlinico San Donato, San Donato Milanese

SA6 6NL

Morriston Hospital - ABM University Health Board, Morriston

BT12 6BA

Royal Victoria Hospital, Belfast